{"stages":[{"name":"landscapes","label":"Landscapes","icon":"&#x1f5fa;","color":"#4fc3f7","table":"landscape_analyses","total":3,"delta_7d":2,"throughput_pct":100.0,"oldest_unprocessed":null,"sla_days":7,"stuck_description":"No linked gap after 7 days","stuck":[],"list_url":"/senate/pipeline/stage/landscapes"},{"name":"gaps","label":"Gaps","icon":"&#x1f50d;","color":"#ffb74d","table":"knowledge_gaps","total":3545,"delta_7d":162,"throughput_pct":0.9,"oldest_unprocessed":null,"sla_days":30,"stuck_description":"status=open/proposed, never debated after 30 days","stuck":[],"list_url":"/senate/pipeline/stage/gaps"},{"name":"debates","label":"Debates","icon":"&#x1f5e3;","color":"#ce93d8","table":"debate_sessions","total":841,"delta_7d":493,"throughput_pct":53.6,"oldest_unprocessed":"2026-04-02T07:31:42.392597+00:00","sla_days":3,"stuck_description":"Debate generated 0 hypotheses after 3 days","stuck":[{"id":"sess_SDA-2026-04-02-gap-20260402-003058","question":"Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidirectional relationship between sleep disorders (particularly circadian rhythm disruption and impaired glymphatic clearance) and neurodegenerative disease progression, focusing on amyloid-beta accumulation, tau pathology, and the therapeutic potential of sleep restoration interventions.","quality_score":0.46,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T07:31:42.392597+00:00","analysis_id":"SDA-2026-04-02-gap-20260402-003058"},{"id":"sess_SDA-2026-04-02-gap-20260402-003115","question":"Is disrupted sleep a cause or consequence of neurodegeneration? Analyze the bidirectional relationship between sleep disorders (particularly circadian rhythm disruption and impaired glymphatic clearance) and neurodegenerative disease progression, focusing on amyloid-beta accumulation, tau pathology, and the therapeutic potential of sleep restoration interventions.","quality_score":0.59,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T07:32:45.316709+00:00","analysis_id":"SDA-2026-04-02-gap-20260402-003115"},{"id":"sess_SDA-2026-04-02-gap-microglial-subtypes-20260402004119","question":"Analyze the spectrum of microglial activation states (DAM, homeostatic, inflammatory) and their distinct roles in AD, PD, and ALS. Identify pharmacological targets for shifting microglia toward protective phenotypes.","quality_score":0.49,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T07:45:41.300763+00:00","analysis_id":"SDA-2026-04-02-gap-microglial-subtypes-20260402004119"},{"id":"sess_SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402","question":"What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. Produce hypotheses about aging-neurodegeneration mechanisms.","quality_score":0.57,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T09:50:58.381614+00:00","analysis_id":"SDA-2026-04-02-gap-aging-mouse-brain-v2-20260402"},{"id":"sess_SDA-2026-04-02-gap-aging-mouse-brain-v3-20260402","question":"What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. Produce hypotheses about aging-neurodegeneration mechanisms.","quality_score":0.5,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T09:55:24.361088+00:00","analysis_id":"SDA-2026-04-02-gap-aging-mouse-brain-v3-20260402"},{"id":"sess_SDA-2026-04-02-gap-seaad-20260402025452","question":"What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transcriptomic data? Use Allen Brain Cell Atlas evidence. Identify mechanisms of cell-type-specific vulnerability in AD pathology.","quality_score":0.56,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T09:55:59.602610+00:00","analysis_id":"SDA-2026-04-02-gap-seaad-20260402025452"},{"id":"sess_SDA-2026-04-02-gap-aging-mouse-brain-v4-20260402","question":"What gene expression changes in the aging mouse brain predict neurodegenerative vulnerability? Use Allen Aging Mouse Brain Atlas data. Cross-reference with human AD datasets. Produce hypotheses about aging-neurodegeneration mechanisms.","quality_score":0.43,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T09:59:27.954382+00:00","analysis_id":"SDA-2026-04-02-gap-aging-mouse-brain-v4-20260402"},{"id":"sess_SDA-2026-04-02-26abc5e5f9f2","question":"Analyze circuit-level changes in neurodegeneration using Allen Institute Neural Dynamics data. Focus on: (1) hippocampal circuit disruption, (2) cortical dynamics alterations, (3) sensory processing changes. Identify circuit-based therapeutic targets connecting genes, proteins, and brain regions to neurodegeneration phenotypes.","quality_score":0.42,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T10:01:41.943540+00:00","analysis_id":"SDA-2026-04-02-26abc5e5f9f2"},{"id":"sess_SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402","question":"Comprehensive analysis of immune cell subtypes in neurodegeneration: microglia subtypes (DAM, homeostatic, inflammatory), astrocyte reactivity states, T-cell infiltration. Anchor to existing TREM2 (h-b234254c, h-044ee057) and complement cascade hypotheses (h-58e4635a, h-1fe4ba9b, h-5a55aabc). Produce inflammatory pathway diagrams and generate 3-5 new hypotheses connecting immune findings to disease mechanisms.","quality_score":0.55,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T10:03:30.826691+00:00","analysis_id":"SDA-2026-04-02-gap-immune-atlas-neuroinflam-20260402"},{"id":"sess_SDA-2026-04-02-gap-seaad-v3-20260402063622","question":"What cell types are most vulnerable in Alzheimers Disease based on SEA-AD transcriptomic data from the Allen Brain Cell Atlas? Identify mechanisms of cell-type-specific vulnerability in neurons, microglia, astrocytes, and oligodendrocytes. Focus on gene expression patterns, pathway dysregulation, and therapeutic implications. Use evidence from the Seattle Alzheimers Disease Brain Cell Atlas.","quality_score":0.57,"num_hypotheses_generated":0,"status":"completed","created_at":"2026-04-02T13:50:55.777806+00:00","analysis_id":"SDA-2026-04-02-gap-seaad-v3-20260402063622"}],"list_url":"/senate/pipeline/stage/debates"},{"name":"hypotheses","label":"Hypotheses","icon":"&#x1f9ec;","color":"#81c784","table":"hypotheses","total":1878,"delta_7d":1129,"throughput_pct":67.8,"oldest_unprocessed":"2026-04-02T14:45:17+00:00","sla_days":14,"stuck_description":"composite_score < 0.5 after 14 days","stuck":[{"id":"h-f9c6fa3f","title":"Microbiome-Derived Tryptophan Metabolite Neuroprotection","composite_score":0.427,"confidence_score":0.3,"target_gene":"AHR, IL10, TGFB1","status":"archived","created_at":"2026-04-02T14:45:17+00:00","analysis_id":"SDA-2026-04-01-gap-20260401-225155"},{"id":"h-7bb47d7a","title":"Bacterial Enzyme-Mediated Dopamine Precursor Synthesis","composite_score":0.384,"confidence_score":0.2,"target_gene":"TH, AADC","status":"archived","created_at":"2026-04-02T14:45:17+00:00","analysis_id":"SDA-2026-04-01-gap-20260401-225155"},{"id":"h-2e7eb2ea","title":"Enteric Nervous System Prion-Like Propagation Blockade","composite_score":0.48,"confidence_score":0.5,"target_gene":"TLR4, SNCA","status":"archived","created_at":"2026-04-02T14:45:17+00:00","analysis_id":"SDA-2026-04-01-gap-20260401-225155"},{"id":"h-7693c291","title":"RNA-Binding Competition Therapy for TDP-43 Cross-Seeding","composite_score":0.465,"confidence_score":0.4,"target_gene":"TARDBP","status":"archived","created_at":"2026-04-03T03:53:40+00:00","analysis_id":"SDA-2026-04-01-gap-9137255b"},{"id":"h-9adb5c9e","title":"Gap Junction Hemichannel Modulation for Controlled Mitochondrial Exchange","composite_score":0.36130000000000007,"confidence_score":0.4,"target_gene":"PANX1","status":"archived","created_at":"2026-04-03T03:53:40+00:00","analysis_id":"SDA-2026-04-01-gap-20260401231108"},{"id":"h-d78123d1","title":"Microglia-Derived Extracellular Vesicle Engineering for Targeted Mitochondrial Delivery","composite_score":0.482,"confidence_score":0.3,"target_gene":"RAB27A/LAMP2B","status":"archived","created_at":"2026-04-03T03:53:40+00:00","analysis_id":"SDA-2026-04-01-gap-20260401231108"},{"id":"h-826df660","title":"Optogenetic Control of Mitochondrial Transfer Networks","composite_score":0.476,"confidence_score":0.4,"target_gene":"ChR2","status":"archived","created_at":"2026-04-03T03:53:40+00:00","analysis_id":"SDA-2026-04-01-gap-20260401231108"},{"id":"h-8bd89d90","title":"Prohibitin-2 Mitochondrial Cross-Seeding Hub Disruption","composite_score":0.469,"confidence_score":0.45,"target_gene":"PHB2","status":"archived","created_at":"2026-04-03T03:53:40+00:00","analysis_id":"SDA-2026-04-01-gap-9137255b"},{"id":"hyp_test_f15ab6d9","title":"Test: TREM2 enhances amyloid clearance","composite_score":0.4,"confidence_score":0.3,"target_gene":"TREM2","status":"archived","created_at":"2026-04-04T12:28:01+00:00","analysis_id":"test-hypothesis-fixtures-v1"},{"id":"h-a11f71b5","title":"Conditional CRISPR Kill Switches for Aberrant Protein Clearance","composite_score":0.4965,"confidence_score":0.3,"target_gene":"UBE3A, PARK2, PINK1","status":"archived","created_at":"2026-04-04T20:38:52+00:00","analysis_id":"SDA-2026-04-03-gap-crispr-neurodegeneration-20260402"}],"list_url":"/senate/pipeline/stage/hypotheses"},{"name":"ranked","label":"Ranked","icon":"&#x1f3c6;","color":"#ffd54f","table":"hypotheses (score≥0.5)","total":1274,"delta_7d":693,"throughput_pct":28.6,"oldest_unprocessed":null,"sla_days":30,"stuck_description":"Ranked hypothesis not linked to any challenge after 30 days","stuck":[],"list_url":"/senate/pipeline/stage/ranked"},{"name":"challenges","label":"Challenges / Experiments","icon":"&#x1f3af;","color":"#ef5350","table":"challenges (276) + experiments (724)","total":1000,"total_challenges":276,"total_experiments":724,"delta_7d":332,"throughput_pct":10.9,"oldest_unprocessed":null,"sla_days":45,"stuck_description":"Open challenge with no linked experiment after 45 days","stuck":[],"list_url":"/senate/pipeline/stage/challenges"}],"generated_at":"2026-04-28T11:58:10.328710+00:00"}